Table 5.
Author | Number of patient presumed Stage I | Re-staging ≤30 days | Final stage | Patient status | DFS (months) | Re-staging >30 days | Final stage | Patient status | DFS (months) |
---|---|---|---|---|---|---|---|---|---|
Graebe et al., 2015[12] | 3 | 2 | 4 | AWD | 3, 5 | ||||
3 | AWD | NA | |||||||
Seidman et al., 2012[32] | 7 | 1 | 3 | DWD | 17 | 3 | 3 | AWD | 39 |
3 | DWD | 27 | |||||||
3 | DWD | 29 | |||||||
Cormio et al., 2015[10] | 3 | 0 | |||||||
Lee et al., 2016[19] | 2 | 0 | |||||||
Einstein et al., 2008[36] | 13 | 2 | 3 | AWD | 31 | ||||
3 | NED | 61 | |||||||
Oduyebo et al., 2014[35] | 10 | 0 | 2 | 3 | DWD | 37.5 | |||
3 | AWD | 8.3 | |||||||
Total (%) | 38 | 5(13) | 5(13) |
AWD: Alive with disease, DFS: Disease-free survival, DWD: Dead with disease, NED: No evidence of disease, NA: Not available